NCT00059657View on ClinicalTrials.gov

Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

November 30, 2005

Conditions
Peripheral Vascular Disease
Interventions
DRUG

Ecraprost in lipid emulsion

Trial Locations (22)

Unknown

Phoenix

Tucson

Glendale

Los Angeles

San Francisco

Pensacola

Springfield

Shawnee Mission

Kenner

Royal Oak

Biloxi

Rochester

Durham

San Antonio

Tacoma

Birmingham

Bristol

Dundee

Hull

London

Manchester

Southhampton

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY